Literature DB >> 9031373

Neonatal lupus syndromes.

C E Tseng1, J P Buyon.   

Abstract

Congenital heart block is considered to be a model of passively acquired autoimmunity, whereby immune abnormalities in the mother lead to the production of autoantibodies that cross the placenta and presumably injure the otherwise normally developing fetus. The major targets of the maternal immune response are the SSA/Ro and SSB/La ribonucleoproteins. Other neonatal abnormalities affecting the skin, liver, and blood elements have also been reported to be associated with anti-SSA/Ro-SSB/La antibodies in the maternal and fetal circulation and are now grouped along with congenital heart block under the heading of the neonatal lupus syndromes. This review covers the histopathology, SSA/Ro-SSB/La antigen-antibody systems, immunogenetics, clinical manifestations, and diagnosis and management strategies of these syndromes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9031373     DOI: 10.1016/s0889-857x(05)70313-6

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  9 in total

Review 1.  Neonatal lupus.

Authors:  Antonio Brucato; Rolando Cimaz; Marco Stramba-Badiale
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

Review 2.  Cardiac involvement in systemic autoimmune diseases.

Authors:  Piersandro Riboldi; Maria Gerosa; Cristina Luzzana; Luca Catelli
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

3.  Neonatal lupus syndrome in a Nigerian child.

Authors:  Moses Abiodun; Olufemi Adelowo
Journal:  BMJ Case Rep       Date:  2012-05-11

Review 4.  Pregnancy in systemic lupus erythematosus.

Authors:  C C Mok; R W Wong
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

5.  Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.

Authors:  Renate Claus; Heiko Hickstein; Thomas Külz; Ute Lenschow; Doris Meiske; Andrea Kotitschke; Hans-Jürgen Thiesen; Peter Lorenz
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

6.  Maternal systemic lupus erythematosus and chondrodysplasia punctata in two sibs: phenocopy or coincidence?

Authors:  N Elçioglu; C M Hall
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

7.  Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly.

Authors:  Gretchen J Mahler; Jonathan T Butcher
Journal:  Int J Inflam       Date:  2011-07-18

8.  Lupus Heart Disease Modeling with Combination of Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Lupus Patient Serum.

Authors:  Narae Park; Yeri Alice Rim; Hyerin Jung; Yoojun Nam; Ji Hyeon Ju
Journal:  Int J Stem Cells       Date:  2021-12-31       Impact factor: 3.011

Review 9.  Clinical and pathological roles of Ro/SSA autoantibody system.

Authors:  Ryusuke Yoshimi; Atsuhisa Ueda; Keiko Ozato; Yoshiaki Ishigatsubo
Journal:  Clin Dev Immunol       Date:  2012-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.